Search Results - "Gelinas, Deborah F."

Immunoglobulin administration for the treatment of CIDP: IVIG or SCIG? by Allen, Jeffrey A., Gelinas, Deborah F., Freimer, Miriam, Runken, M. Chris, Wolfe, Gil I.

“…Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired neurological disorder characterized clinically by weakness and impaired sensory…”
Get full text

MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS) by Zhang, Rongzhen, Gascon, Ron, Miller, Robert G., Gelinas, Deborah F., Mass, Jason, Lancero, Mariselle, Narvaez, Amy, McGrath, Michael S.

“…Recent studies suggest that monocyte activation may play a role in ALS pathogenesis. Therefore, monocyte CCR2, the receptor for monocyte chemoattractant…”
Get full text

Provisional best practices guidelines for the evaluation of bulbar dysfunction in amyotrophic lateral sclerosis by Pattee, Gary L., Plowman, Emily K., (Focht) Garand, Kendrea L., Costello, John, Brooks, Benjamin Rix, Berry, James D., Smith, Richard A., Atassi, Nazem, Chapin, Jennifer L., Yunusova, Yana, McIlduff, Courtney E., Young, Eufrosina, Macklin, Eric A., Locatelli, Eduardo R., Silani, Vincenzo, Heitzman, Daragh, Wymer, James, Goutman, Stephen A., Gelinas, Deborah F., Perry, Bridget, Nalipinski, Paige, Stipancic, Kaila, O'Brien, Meghan, Sullivan, Stacey L., Pioro, Erik P., Gargiulo, Gisella, Green, Jordan R.

“…Introduction: Universally established comprehensive clinical bulbar scales objectively assessing disease progression in amyotrophic lateral sclerosis (ALS) are…”
Get full text

Best practices protocol for the evaluation of bulbar dysfunction: summary recommendations from the NEALS bulbar subcommittee symposium by Pattee, Gary L, Plowman, Emily K, Brooks, Benjamin R, Berry, James D, Atassi, Nazem, Chapin, Jennifer L, Garand, Kendrea, Yunusova, Yana, Mcilduff, Courtney E, Young, Eufrosina, Costello, John M, Macklin, Eric A, Locatelli, Eduardo R, Silani, Vincenzo, Heitzman, Daragh, Wymer, James, Goutman, Stephen A, Gelinas, Deborah F, Smith, Richard, Perry, Bridget, Nalipinski, Paige, Stipancic, Kaila, O'Brien, Meghan, Sullivan, Stacey L, Green, Jordan

“…The aim of this Symposium was to develop a consensus based, bulbar assessment protocol for implementation within NEALS clinics. A one-day symposium, held in…”
Get full text

Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS) by Zhang, Rongzhen, Gascon, Ron, Miller, Robert G., Gelinas, Deborah F., Mass, Jason, Hadlock, Ken, Jin, Xia, Reis, Jeremy, Narvaez, Amy, McGrath, Michael S.

“…Sporadic amyotrophic lateral sclerosis (sALS) is a progressive neuroinflammatory disease of spinal cord motor neurons of unclear etiology. Blood from 38…”
Get full text

Hope in palliative care: from narcissism to self-transcendence in amyotrophic lateral sclerosis by Fanos, Joanna H, Gelinas, Deborah F, Foster, Reed S, Postone, Norman, Miller, Robert G

“…The concept of hope in palliative care is an important and neglected area of research. Amyotrophic lateral sclerosis (ALS), a progressive degenerative motor…”
Get more information

Amyotrophic lateral sclerosis by Gelinas, Deborah, Miller, Robert G, O'Connor, Patricia

“…ALS is not a curable disease, but it is a treatable one. Treatments are now available that can make a major difference in prolonging life and enhancing the…”
Get full text

"You have shown me my end": Attitudes toward presymptomatic testing for familial amyotrophic lateral sclerosis by Fanos, Joanna H., Gelinas, Deborah F., Miller, Robert G.

“…Amyotrophic lateral sclerosis (ALS) is a lethal degenerative motor neuron disease. Approximately, 5–10% of cases of ALS are familial (FALS), inherited…”
Get full text

Quality of life for ventilator-dependent ALS patients and their caregivers by Gelinas, Deborah F, O'Connor, Patricia, Miller, Robert G

“…Seven ventilator-dependent ALS patients and eleven caregivers were interviewed in order to assess the impact of ventilator-dependence on patients and their…”
Get full text

Pulmonary function screening by Gelinas, Deborah F

“…Patients who suffer from neuromuscular diseases often have complications from respiratory insufficiencies. Some neuromuscular diseases, for example Landry…”
Get more information

Creatine monohydrate in ALS: Effects on strength, fatigue, respiratory status and ALSFRS by Rosenfeld, Jeffrey, King, Ruth M., Jackson, Carlayne E., Bedlack, Richard S., Barohn, Richard J., Dick, Arthur, Phillips, Lawrence H., Chapin, John, Gelinas, Deborah F., Lou, Jau-Shin

“…Our objective was to determine the effect of creatine monohydrate on disease progression in patients with amyotrophic lateral sclerosis (ALS). One hundred and…”
Get full text

A comparison of maximal inspiratory pressure and forced vital capacity as potential criteria for initiating non-invasive ventilation in amyotrophic lateral sclerosis by Mendoza, Michelle, Gelinas, Deborah F., Moore, Dan H., Miller, Robert G.

“…Using a retrospective analysis of 161 patients with amyotrophic lateral sclerosis (ALS) from the Western ALS study group (WALS) database, the sensitivity of…”
Get full text

Vital capacity as an efficacy measure: Summary by Gelinas, Deborah F

Get full text

Riluzole by Gelinas, Deborah F

Get full text

Patient and caregiver communications and decisions by GELINAS, D. F

Get full text

Measurement of Health-Related Quality of Life in Patients with Amyotrophic Lateral Sclerosis in Clinical Trials of New Therapies by Damiano, Anne M., Patrick, Donald L., Guzman, Gladys I., Gawel, Marek J., Gelinas, Deborah F., Natter, Howard M., Ingalls, Kathleen K.

“…Objectives. Recent trials of amyotrophic lateral sclerosis (ALS) therapies have included the Sickness Impact Profile (SIP) to evaluate health-related quality…”
Get full text

RESPIRATORY COMPLICATIONS OF AMYOTROPHIC LATERAL SCLEROSIS: SYMPTOMS, SIGNS, DIAGNOSIS, AND TREATMENT by Gelinas, Deborah F

“…Amyotrophic lateral sclerosis (ALS) is a progressively paralyzing disease resulting in death, usually due to respiratory complications. Signs and symptoms of…”
Get full text

ALS standard of care consensus by MILLER, R. G, SUFIT, R, MITSUMOTO, H, GELINAS, D. F, BROOKS, B. R

Get full text

Cost effectiveness of recombinant human insulin-like growth factor I therapy in patients with ALS by Ackerman, S J, Sullivan, E M, Beusterien, K M, Natter, H M, Gelinas, D F, Patrick, D L

“…Amyotrophic lateral sclerosis (ALS) is a fatal, degenerative neuromuscular disease characterised by a progressive loss of voluntary motor activity. Recombinant…”
Get full text

Best practices protocol for the evaluation of bulbar dysfunction: summary recommendations from the NEALS bulbar subcommittee symposium by Pattee, Gary L., Plowman, Emily K., Brooks, Benjamin R., Berry, James D., Atassi, Nazem, Chapin, Jennifer L., Garand, Kendrea, Yunusova, Yana, Mcilduff, Courtney E., Young, Eufrosina, Costello, John M., Macklin, Eric A., Locatelli, Eduardo R., Silani, Vincenzo, Heitzman, Daragh, Wymer, James, Goutman, Stephen A., Gelinas, Deborah F., Smith, Richard, Perry, Bridget, Nalipinski, Paige, Stipancic, Kaila, O'Brien, Meghan, Sullivan, Stacey L., Green, Jordan

“…Objective: The aim of this Symposium was to develop a consensus based, bulbar assessment protocol for implementation within NEALS clinics. Methods: A one-day…”
Get full text